Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions.

Major, Ajay; Cliff, Edward R Scheffer; Ermann, Daniel A; Durani, Urshila; Russler-Germain, David A.

Afiliação

Major A; Section of Hematology/Oncology, Department of Medicine University of Chicago Chicago Illinois USA.
Cliff ERS; Department of Health Policy and Management Harvard T.H. Chan School of Public Health Boston Massachusetts USA.
Ermann DA; Program on Regulation, Therapeutics and Law Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA.
Durani U; Department of Hematology/Oncology, Huntsman Cancer Institute University of Utah Salt Lake City Utah USA.
Russler-Germain DA; Division of Hematology, Department of Medicine Mayo Clinic Rochester Minnesota USA.

EJHaem ; 3(3): 930-935, 2022 Aug.

Article em En | MEDLINE | ID: mdl-36051026